InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: None

Thursday, 12/10/2020 5:33:12 PM

Thursday, December 10, 2020 5:33:12 PM

Post# of 198600
Has anyone seen this???

JUST OUT TODAY!!! 12/10/20

It appears Harry is aggressively expanding the Company's clinical treatment applications now that we're at Texas A&M by introducing a new Patent!

https://www.accesswire.com/620448/Enzolytics-Inc-Files-Provisional-Patent-for-Treatment-of-Multiple-Sclerosis

PLANO, TX / ACCESSWIRE / December 10, 2020 / Enzolytics, Inc. (OTC PINK:ENZC or the "Company") today announced the filing of a provisional patent with the U.S. Patent Office on December 9, 2020 for a treatment of Multiple Sclerosis developed by Harry Zhabilov, titled NUCLEAR PROTEINS ISOLATED FROM MAMALIAN SPINAL CORD (SCNP) IMMUNE FACTOR, Ser. No. 62/123341. The Company received confirmation of filing from the U.S. Patent Office today.

The Patent covers Pharmaceutical compositions developed by the inventor Harry Zhabilov, CSO of the Company, which are suitable for the treatment of several disorders including certain immune disorders, congenital defects involving primary T cell deficiency, viral infections, HIV and immunosuppression following cancer treatment.

The new proprietary technology will be developed by ENZC in combination with its ongoing development of monoclonal antibodies against both HIV and the CoronaVirus in our recently established laboratory facility at Texas A & M University's Institute for Preclinical Studies.

Cheers!

Be well and prosper...